Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.




) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.5%. By the end of trading, WellPoint fell $1.25 (-1.4%) to $89.68 on average volume. Throughout the day, 2,531,799 shares of WellPoint exchanged hands as compared to its average daily volume of 2,399,100 shares. The stock ranged in price between $89.52-$91.66 after having opened the day at $91.66 as compared to the previous trading day's close of $90.93. Other companies within the Health Care sector that declined today were:

Aoxing Pharmaceutical Company



), down 16.0%,




), down 13.2%,

Tenet Healthcare



TheStreet Recommends

), down 9.1% and

Star Scientific



), down 8.8%.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical and specialty products in the United States. WellPoint has a market cap of $26.2 billion and is part of the health services industry. Shares are down 1.6% year to date as of the close of trading on Monday. Currently there are 6 analysts that rate WellPoint a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates


as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front,




), up 170.8%,

DARA Biosciences



), up 23.1%,

Genocea Biosciences



), up 21.1% and

Sunesis Pharmaceuticals



), up 17.5% , were all gainers within the health care sector with

Forest Laboratories



) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care




STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.